{"ModuleTitle": "Company Description", "CompanyName": "Aeterna Zentaris Inc.", "Symbol": "AEZS", "Address": "C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR, MONTREAL, H3B 3V2, Canada", "Phone": "843-900-3201", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a specialty biopharmaceutical company engaged in commercializing novel\r\npharmaceutical therapies, principally through out-licensing arrangements.  We\r\nare a party to a License Agreement with Novo to carry out development,\r\nmanufacturing, registration, regulatory and supply chain services for the\r\ncommercialization of Macrilen(TM) (macimorelin), which is to be used in the\r\ndiagnosis of patients with AGHD, in the U.S. and Canada.  In addition, we are\r\nactively pursuing business development opportunities for macimorelin in the ROW\r\nand to monetize the value of our non-strategic assets.\r\n\r\n \r\n\r\nWe were incorporated on September 12, 1990 under the Canada Business\r\nCorporations Act (the \"CBCA\") and continue to be governed by the CBCA. Our\r\nregistered address is located at 5300 Commerce Court West, 199 Bay Street,\r\nToronto, Ontario, Canada M5L 1B9 c/o Stikeman Elliott LLP; the telephone number\r\nfor the registered address is (416) 869-5500.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f31%2f0001493152-20-005347.html#FIS_COMPANY_INFORMATION\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Klaus Paulini", "title": "President, Chief Executive Officer & Director"}, {"name": "Leslie Auld", "title": "Chief Financial Officer & Senior Vice President"}, {"name": "Nicola Ammer", "title": "Chief Medical Officer & VP-Clinical Development"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}